3,111 research outputs found
New Approach to Parton Shower MC's for Precision QCD Theory: HERWIRI1.0(31)
By implementing the new IR-improved
Dokshitzer-Gribov-Lipatov-Altarelli-Parisi-Callan-Symanzik (DGLAP-CS) kernels
recently developed by one of us in the HERWIG6.5 environment we generate a new
MC, HERWIRI1.0(31), for hadron-hadron scattering at high energies. We use MC
data to illustrate the comparison between the parton shower generated by the
standard DGLAP-CS kernels and that generated by the new IR-improved DGLAP-CS
kernels. The interface to MC@NLO, MC@NLO/HERWIRI, is illustrated. Comparisons
with FNAL data and some discussion of possible implications for LHC
phenomenology are also presented.Comment: 24 pages, 10 figures; published versio
Analysis of the Malaysian Toll Road Public-Private Partnership Program and Recommendations for Policy Improvements
Malaysia has relied on toll road public-private partnerships (PPPs) for over twenty years to provide important highway infrastructure. The program has been active with nearly 1800 kilometers either constructed or concessions agreed to. The public has been less supportive of the program due to low transparency and little public involvement. Public protests are common, which may lead to long-term program instability. The CLIOS Process, developed at MIT, is applied to Malaysia’s toll road PPP program to develop new policies that can better meet these public concerns while maintaining the financial viability of the sector. With increases in transparency and public involvement, the political risks of the program should be reduced and long-term stability for the government and concessionaires improved. We argue that the focus should be at the regional transportation planning level where toll road PPPs can be compared with alternatives for meeting transportation needs rather than at the national level where Malaysian toll road PPPs are currently handled
Graphene formation on SiC substrates
Graphene layers were created on both C and Si faces of semi-insulating,
on-axis, 4H- and 6H-SiC substrates. The process was performed under high vacuum
(<10-4 mbar) in a commercial chemical vapor deposition SiC reactor. A method
for H2 etching the on-axis sub-strates was developed to produce surface steps
with heights of 0.5 nm on the Si-face and 1.0 to 1.5 nm on the C-face for each
polytype. A process was developed to form graphene on the substrates
immediately after H2 etching and Raman spectroscopy of these samples confirmed
the formation of graphene. The morphology of the graphene is described. For
both faces, the underlying substrate morphology was significantly modified
during graphene formation; sur-face steps were up to 15 nm high and the uniform
step morphology was sometimes lost. Mo-bilities and sheet carrier
concentrations derived from Hall Effect measurements on large area (16 mm
square) and small area (2 and 10 um square) samples are presented and shown to
compare favorably to recent reports.Comment: European Conference on Silicon Carbide and Related Materials 2008
(ECSCRM '08), 4 pages, 4 figure
Recommended from our members
Reducing patients’ exposures to asthma and allergy triggers in their homes: an evaluation of effectiveness of grades of forced air ventilation filters
Objective: Many interventions to reduce allergen levels in the home are recommended to asthma and allergy patients. One that is readily available and can be highly effective is the use of high performing filters in forced air ventilation systems. Methods: We conducted a modeling analysis of the effectiveness of filter-based interventions in the home to reduce airborne asthma and allergy triggers. This work used “each pass removal efficiency” applied to health-relevant size fractions of particles to assess filter performance. We assessed effectiveness for key allergy and asthma triggers based on applicable particle sizes for cat allergen, indoor and outdoor sources of particles 70% for cat dander particles, fine particulate matter (PM2.5) and respiratory virus can lower concentrations of those asthma triggers and allergens in indoor air of the home by >50%. Very high removal efficiency filters, such as those rated a 16 on the nationally recognized Minimum Efficiency Removal Value (MERV) rating system, tend to be only marginally more effective than MERV12 or 13 rated filters. Conclusions: The results of this analysis indicate that use of a MERV12 or higher performing air filter in home ventilation systems can effectively reduce indoor levels of these common asthma and allergy triggers. These reductions in airborne allergens in turn may help reduce allergy and asthma symptoms, especially if employed in conjunction with other environmental management measures recommended for allergy and asthma patients
The effect of deworming on growth in one-year-old children living in a soil-transmitted helminth-endemic area of Peru: a randomized controlled trial
BACKGROUND:Appropriate health and nutrition interventions to prevent long-term adverse effects in children are necessary before two years of age. One such intervention may include population-based deworming, recommended as of 12 months of age by the World Health Organization in soil-transmitted helminth (STH)-endemic areas; however, the benefit of deworming has been understudied in early preschool-age children. METHODOLOGY/PRINCIPAL FINDINGS:A randomized, double-blind, placebo-controlled trial was conducted to determine the effect of deworming (500 mg single-dose crushed mebendazole tablet) on growth in one-year-old children in Iquitos, Peru. Children were enrolled during their routine 12-month growth and development clinic visit and followed up at their 18 and 24-month visits. Children were randomly allocated to: Group 1: deworming at 12 months and placebo at 18 months; Group 2: placebo at 12 months and deworming at 18 months; Group 3: deworming at both 12 and 18 months; or Group 4: placebo at both 12 and 18 months (i.e. control group). The primary outcome was weight gain at the 24-month visit. An intention-to-treat approach was used. A total of 1760 children were enrolled between September 2011 and June 2012. Follow-up of 1563 children (88.8%) was completed by July 2013. STH infection was of low prevalence and predominantly light intensity in the study population. All groups gained between 1.93 and 2.05 kg on average over 12 months; the average difference in weight gain (kg) compared to placebo was: 0.05 (95% CI: -0.05, 0.17) in Group 1; -0.07 (95%CI: -0.17, 0.04) in Group 2; and 0.04 (95%CI: -0.06, 0.14) in Group 3. There was no statistically significant difference in weight gain in any of the deworming intervention groups compared to the control group. CONCLUSIONS:Overall, with one year of follow-up, no effect of deworming on growth could be detected in this population of preschool-age children. Low baseline STH prevalence and intensity and/or access to deworming drugs outside of the trial may have diluted the potential effect of the intervention. Additional research is required to overcome these challenges and to contribute to strengthening the evidence base on deworming. TRIAL REGISTRATION:ClinicalTrials.gov (NCT01314937)
Impairment of early fracture healing by skeletal muscle trauma is restored by FK506
BACKGROUND:
Heightened local inflammation due to muscle trauma or disease is associated with impaired bone regeneration.
METHODS:
We hypothesized that FK506, an FDA approved immunomodulatory compound with neurotrophic and osteogenic effects, will rescue the early phase of fracture healing which is impaired by concomitant muscle trauma in male (~4 months old) Lewis rats. FK506 (1 mg/kg; i.p.) or saline was administered systemically for 14 days after an endogenously healing tibia osteotomy was created and fixed with an intermedullary pin, and the overlying tibialis anterior (TA) muscle was either left uninjured or incurred volumetric muscle loss injury (6 mm full thickness biopsy from middle third of the muscle).
RESULTS:
The salient observations of this study were that 1) concomitant TA muscle trauma impaired recovery of tibia mechanical properties 28 days post-injury, 2) FK506 administration rescued the recovery of tibia mechanical properties in the presence of concomitant TA muscle trauma but did not augment mechanical recovery of an isolated osteotomy (no muscle trauma), 3) T lymphocytes and macrophage presence within the traumatized musculature were heightened by trauma and attenuated by FK506 3 days post-injury, and 4) T lymphocyte but not macrophage presence within the fracture callus were attenuated by FK506 at 14 days post-injury. FK506 did not improve TA muscle isometric torque production CONCLUSION: Collectively, these findings support the administration of FK506 to ameliorate healing of fractures with severe muscle trauma comorbidity. The results suggest one potential mechanism of action is a reduction in local T lymphocytes within the injured musculoskeletal tissue, though other mechanisms to include direct osteogenic effects of FK506 require further investigation
Antibiotic-induced perturbations in gut microbial diversity influences neuro-inflammation and amyloidosis in a murine model of Alzheimer’s disease
Severe amyloidosis and plaque-localized neuro-inflammation are key pathological features of Alzheimer’s disease (AD). In addition to astrocyte and microglial reactivity, emerging evidence suggests a role of gut microbiota in regulating innate immunity and influencing brain function. Here, we examine the role of the host microbiome in regulating amyloidosis in the APP(SWE)/PS1(ΔE9) mouse model of AD. We show that prolonged shifts in gut microbial composition and diversity induced by long-term broad-spectrum combinatorial antibiotic treatment regime decreases Aβ plaque deposition. We also show that levels of soluble Aβ are elevated and that levels of circulating cytokine and chemokine signatures are altered in this setting. Finally, we observe attenuated plaque-localised glial reactivity in these mice and significantly altered microglial morphology. These findings suggest the gut microbiota community diversity can regulate host innate immunity mechanisms that impact Aβ amyloidosis
- …
